EP0030795A3
(en)
*
|
1979-12-06 |
1981-09-09 |
Imperial Chemical Industries Plc |
Quinoxaline derivatives, processes therefor, pharmaceutical compositions, and benzene derivatives
|
DE3032994A1
(de)
*
|
1980-09-02 |
1982-04-22 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue pyrazino-azepine, deren herstellung und diese sie enthaltende arzneimittel
|
JPS62198671A
(ja)
*
|
1986-02-25 |
1987-09-02 |
Toyo Jozo Co Ltd |
1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
|
JPS62281878A
(ja)
*
|
1986-02-26 |
1987-12-07 |
Taisho Pharmaceut Co Ltd |
アザアントラセン化合物
|
JPH0678319B2
(ja)
*
|
1986-03-11 |
1994-10-05 |
東ソー株式会社 |
キノキサリノン誘導体
|
JPS6450868A
(en)
*
|
1987-08-21 |
1989-02-27 |
Toyo Jozo Kk |
1-substituted alkyl-2-oxo-1,2-dihydroquinoxaline derivative
|
JPH0276860A
(ja)
*
|
1987-10-05 |
1990-03-16 |
Toyo Jozo Co Ltd |
6−置換アルコキシ−2−オキソ−1,2−ジヒドロキノキサリン誘導体
|
NO179551C
(no)
*
|
1987-11-10 |
1996-10-30 |
Novo Nordisk As |
Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
|
GB9413975D0
(en)
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
WO1992011245A1
(en)
*
|
1990-12-20 |
1992-07-09 |
Warner-Lambert Company |
2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
|
DE4217952A1
(de)
*
|
1992-05-30 |
1993-12-02 |
Basf Ag |
Chinoxalin-2,3(1H,4H)-dione
|
FR2696456B1
(fr)
*
|
1992-10-07 |
1995-01-06 |
Pf Medicament |
Dérivés de dihydro-1,2 oxo amino-3 quinoxalines, leur préparation et leur application en thérapeutique.
|
DE4340045A1
(de)
*
|
1993-11-24 |
1995-06-01 |
Basf Ag |
Neue Chinoxaline und Arzneimittel daraus
|
US5620978A
(en)
*
|
1994-01-03 |
1997-04-15 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon |
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor
|
GB2291422A
(en)
*
|
1994-07-18 |
1996-01-24 |
Fujisawa Pharmaceutical Co |
4-phenyl-pyrido[2,3-b]pyrazin-4-ones
|
FR2731221B1
(fr)
*
|
1995-03-01 |
1997-05-30 |
Pf Medicament |
Nouveaux derives de l'ethyl-1 dihydro-1, 2 oxo-2 methylamino-3 quinoxaline, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
|
GB9526558D0
(en)
*
|
1995-12-27 |
1996-02-28 |
Fujisawa Pharmaceutical Co |
Heterobicyclic derivatives
|
ZA973884B
(en)
*
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
EP1380298A3
(en)
*
|
1996-05-23 |
2004-04-07 |
Bristol-Myers Squibb Pharma Company |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders, anorexia, inflammation
|
US5869487A
(en)
*
|
1996-10-24 |
1999-02-09 |
Merck & Co., Inc. |
Pyrido 3,4-B!pyrazines for use as thrombin inhibitors
|
US6087373A
(en)
*
|
1997-09-23 |
2000-07-11 |
Merck & Co., Inc. |
Thrombin inhibitors
|
AU5758199A
(en)
*
|
1998-09-29 |
2000-04-17 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel salts of pyridopyrazine compound and crystals thereof
|
US6239132B1
(en)
|
1999-04-23 |
2001-05-29 |
Merck & Co., Inc. |
Thrombin inhibitors
|
AU5451400A
(en)
|
1999-06-04 |
2000-12-28 |
Merck & Co., Inc. |
Thrombin inhibitors
|
PL366577A1
(en)
*
|
2001-05-14 |
2005-02-07 |
Bristol-Myers Squibb Pharma Company |
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
|
SE0302324D0
(sv)
*
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302323D0
(sv)
*
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302486D0
(sv)
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
Novel compounds
|
CN1886389B
(zh)
*
|
2003-09-30 |
2010-07-21 |
詹森药业有限公司 |
喹喔啉化合物
|
EP1685115A1
(en)
*
|
2003-11-03 |
2006-08-02 |
Warner-Lambert Company LLC |
Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
|
KR20060130159A
(ko)
*
|
2004-01-06 |
2006-12-18 |
얀센 파마슈티카 엔.브이. |
당뇨병 및 비만증 치료용 글리코겐 인산화효소억제제로서의(3-옥소-3,4-디하이드로-퀴녹살린-2-일-아미노)-벤즈아미드유도체 및 관련 화합물
|
JP2008509212A
(ja)
*
|
2004-08-09 |
2008-03-27 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
中枢神経系障害の治療のための新規なキノキサリノンノルエピネフリン再吸収阻害剤
|
US7601716B2
(en)
*
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
TW200808771A
(en)
|
2006-05-08 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds II
|
TW200808763A
(en)
|
2006-05-08 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds I
|
DE102007050673A1
(de)
|
2007-10-19 |
2009-04-23 |
Friedrich-Schiller-Universität Jena |
Neue Hexaaza-acene und Verfahren zu ihrer Herstellung
|
TW200924770A
(en)
|
2007-11-06 |
2009-06-16 |
Astrazeneca Ab |
Novel compounds 089
|
JP5735806B2
(ja)
|
2008-03-05 |
2015-06-17 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
ピリドピラジノン誘導体インスリン分泌刺激剤、それらを得る方法および糖尿病を治療するためのそれらの使用
|
KR101637381B1
(ko)
|
2008-03-05 |
2016-07-07 |
메르크 파텐트 게엠베하 |
인슐린 분비 자극제들로서의 피라지논 유도체들, 이들을 얻기 위한 방법들 및 당뇨병 치료를 위한 이들의 용도
|
TW201036957A
(en)
|
2009-02-20 |
2010-10-16 |
Astrazeneca Ab |
Novel salt 628
|
US8859803B2
(en)
|
2009-06-26 |
2014-10-14 |
Ihara Chemical Industry Co., Ltd. |
Process for production of ketomalonic acid compounds or hydrates thereof
|
KR20120099639A
(ko)
|
2009-10-02 |
2012-09-11 |
아스트라제네카 아베 |
호중구 엘라스타제의 억제제로서 사용되는 2-피리돈 화합물
|
JP5921500B2
(ja)
|
2013-07-19 |
2016-05-24 |
イハラケミカル工業株式会社 |
ケトマロン酸化合物の製造方法
|
KR102134407B1
(ko)
|
2014-02-17 |
2020-07-15 |
구미아이 가가쿠 고교 가부시키가이샤 |
유통 반응기를 사용한 케토말론산 화합물의 연속 제조방법
|
NZ743725A
(en)
*
|
2015-12-24 |
2024-11-29 |
Univ California |
Cftr regulators and methods of use thereof
|
AU2016379444B2
(en)
|
2015-12-24 |
2021-04-29 |
The Regents Of The University Of California |
CFTR regulators and methods of use thereof
|
EP3672598A4
(en)
|
2017-08-24 |
2021-04-28 |
The Regents of The University of California |
MEDICINAL COMPOSITIONS FOR THE EYE
|